Clinical Trial Update: Safety of Intravenous Neridronic Acid in CRPS [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing the safety of intravenous neridronic acid in Complex Regional Pain Syndrome has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Regional Pain Syndrome

Drugs mentioned

• neridronic acid (neridronate)

Snippet

Sponsor: Grünenthal GmbH | Conditions: Complex Regional Pain Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2019-11-04